NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) investors ...
All the signs were Aberdeen would wait until the summer to appoint a new manager - so why have they moved for Stephen Robinson now?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results